MedTrace Logo

Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)

NCT03571802 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-08

No results posted yet for this study

Summary

This study aims to investigate the change in systemic exposure of simvastatin post LSG.

Conditions

Interventions

DRUG

Simvastatin

* The subject will take simvastatin 20mg at 0 h (after stopping simvastatin for 5 days). 5 mL of blood will be sampled at 0 h, 1 h, 2 h, 3 h, 5 h, 7 h. * There will be 2 blood sampling sessions: 1 before and the other 3 months after surgery.

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Asim Shabbir, MBBS · National University Hospital, Singapore

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2025-06-30
Completion
2025-06-30
FDA Drug
Yes

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571802 on ClinicalTrials.gov